Yes, muscular dystrophy is a genetic condition in every known form. It is caused by mutations in genes responsible for building and maintaining muscle fibers. However, “genetic” doesn’t always mean “inherited from a parent.” About one-third of Duchenne muscular dystrophy cases arise from spontaneous new mutations in families with no prior history of the disease.
How Duchenne and Becker MD Are Inherited
Duchenne muscular dystrophy (DMD), the most common and severe form, follows an X-linked inheritance pattern. The mutation sits on the X chromosome, which means it overwhelmingly affects boys. Males have only one X chromosome, so a single defective copy of the gene is enough to cause the disease. Females have two X chromosomes, so a working backup copy on the second X typically compensates, making them carriers rather than patients. About 1 in every 5,000 males between ages 5 and 9 has Duchenne or its milder relative, Becker muscular dystrophy. Duchenne is roughly three times more common than Becker.
The math for carrier mothers is straightforward. With each pregnancy, a carrier woman has a 50% chance of passing on the affected X chromosome. That means each son has a 50% chance of having the condition, and each daughter has a 50% chance of becoming a carrier herself. If a male with DMD were to have children, all of his daughters would be carriers, but none of his sons would be affected, because sons inherit their father’s Y chromosome, not his X.
Spontaneous Mutations Without Family History
One of the most important things to understand is that roughly 33% of Duchenne cases are caused by brand-new mutations that weren’t present in either parent’s DNA. These are called de novo mutations. A family can have no history of muscular dystrophy whatsoever and still have a child diagnosed with it. In some cases, a parent carries the mutation only in their egg or sperm cells (a phenomenon called gonadal mosaicism) but not in the rest of their body, so standard blood-based carrier testing would miss it entirely. This is why prenatal testing is still recommended even for mothers who test negative as carriers if they already have one affected son.
Not All Types Follow the Same Pattern
Muscular dystrophy is not a single disease. It’s a group of over 30 genetic conditions, and they don’t all inherit the same way. Duchenne and Becker are X-linked, but many other forms follow completely different rules.
Limb-girdle muscular dystrophies (LGMD), which cause weakness primarily in the shoulders and hips, are inherited through non-sex chromosomes. Some forms are autosomal dominant, meaning a single copy of the mutated gene from one parent is enough to cause disease. Others are autosomal recessive, meaning a child must inherit a defective copy from both parents. The recessive forms are more common, and because both parents can be silent carriers with no symptoms, these cases can also appear to come out of nowhere.
Facioscapulohumeral muscular dystrophy (FSHD), which primarily affects the face, shoulders, and upper arms, has an unusual genetic mechanism. It involves a gene called DUX4 that is normally active only during early embryonic development and then permanently silenced. In FSHD, a change in chromosome 4 causes this gene to reactivate in muscle tissue, where it doesn’t belong. About 95% of FSHD cases (classified as FSHD1) result from a shortening of a repetitive DNA segment on that chromosome. FSHD typically follows an autosomal dominant pattern, so a parent with the condition has a 50% chance of passing it to each child regardless of sex.
Myotonic Dystrophy and Repeat Expansions
Myotonic dystrophy, the most common form of adult-onset muscular dystrophy, is caused by a different type of mutation altogether. Instead of a gene being deleted or broken, a short segment of DNA is repeated too many times, like a stutter in the genetic code. In myotonic dystrophy type 1, a three-letter sequence (CTG) in the relevant gene is normally repeated fewer than 37 times. People with the condition have between 50 and 1,000 repeats, and those born with the most severe congenital form can have more than 1,000.
The number of repeats tends to grow from one generation to the next, which means the disease often gets more severe and appears earlier in life with each successive generation. A grandparent might have mild symptoms in middle age, a parent might develop noticeable weakness in their 30s, and a child could be affected from birth. This pattern, called anticipation, is one of the hallmarks of repeat expansion diseases. Myotonic dystrophy is autosomal dominant, so it affects males and females equally.
Genetic Testing and Diagnosis
Confirming a diagnosis of muscular dystrophy now relies heavily on genetic testing rather than muscle biopsies alone. For Duchenne and Becker, the first step is typically a test that checks whether whole sections of the gene have been deleted or duplicated, which accounts for about 80% of cases. If that comes back normal, full gene sequencing looks for smaller mutations in any of the gene’s 79 sections, which covers the remaining 20%.
Getting the exact genetic diagnosis matters for several reasons beyond confirming the condition. It determines which specific treatments a patient may qualify for. In June 2023, the FDA approved the first gene therapy for Duchenne, though it was initially limited to boys aged 4 to 5. The type and location of the mutation also dictates eligibility for other targeted therapies. And identifying the precise mutation is essential for testing other family members who may be carriers.
Carrier Testing and Family Planning
For families with a known history of muscular dystrophy, carrier testing can clarify who is at risk of passing on the condition. The process starts with identifying the exact mutation in the affected family member, then testing relatives for the same change. For X-linked forms like Duchenne, this primarily means testing female relatives who could be carriers.
Prenatal testing during pregnancy is available once the family’s specific mutation is known. Because gonadal mosaicism can cause a mother to pass on a mutation that doesn’t show up in her own blood tests, genetic counselors often recommend prenatal testing even when the mother appears not to be a carrier. For autosomal recessive forms like many limb-girdle dystrophies, both parents need to carry the same gene mutation for a child to be affected, and each pregnancy carries a 25% chance if both are carriers.
Genetic counseling helps families understand their specific risk numbers and reproductive options, which vary significantly depending on the type of muscular dystrophy, the inheritance pattern, and whether the mutation in the family is already identified.